News & Articles

The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories

Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic

Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis

Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models

Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process

Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells

Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment

The multiplex PCR test is capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers

Study finds switches near GDF5 gene linked to knee osteoarthritis, hip dysplasia

Dr. Lique Coolen and Dr. Aleisha Moore, Kent State University, present their latest research into the mechanisms underlying spinal cord injury and neuroendocrine dysfunction

Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment

The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients

LGC has been working with NHS Test and Trace to support the UK's response to the pandemic

VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies

Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand

Univercells Technologies will work with VectorBuilder to develop and optimize NevoLine Upstream platform and scale-X bioreactors for the production of custom viral vectors